{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T10:43:33Z","timestamp":1779878613352,"version":"3.53.1"},"reference-count":64,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2012,3,28]],"date-time":"2012-03-28T00:00:00Z","timestamp":1332892800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0033864","type":"journal-article","created":{"date-parts":[[2012,3,28]],"date-time":"2012-03-28T21:14:57Z","timestamp":1332969297000},"page":"e33864","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":61,"title":["Ocular Application of the Kinin B1 Receptor Antagonist LF22-0542 Inhibits Retinal Inflammation and Oxidative Stress in Streptozotocin-Diabetic Rats"],"prefix":"10.1371","volume":"7","author":[{"given":"Myl\u00e8ne","family":"Pouliot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"S\u00e9n\u00e9cal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Dotigny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvire","family":"Vaucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9jean","family":"Couture","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,3,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/ki.2008.9","article-title":"The kallikrein-kinin system in diabetic retinopathy: lessons for the kidney.","volume":"73","author":"JA Phipps","year":"2008","journal-title":"Kidney Int"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.2174\/1381612043383179","article-title":"Angiotensin and bradykinin: targets for the treatment of vascular and neuro-glial pathology in diabetic retinopathy.","volume":"10","author":"JL Wilkinson-Berka","year":"2004","journal-title":"Curr Pharm Des"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s11892-010-0127-1","article-title":"Plasma kallikrein and diabetic macular edema.","volume":"10","author":"EP Feener","year":"2010","journal-title":"Curr Diab Rep"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0014-2999(01)01318-8","article-title":"Kinin receptors in pain and inflammation.","volume":"429","author":"R Couture","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0031-6997(25)06836-X","article-title":"Pharmacology of bradykinin and related kinins.","volume":"32","author":"D Regoli","year":"1980","journal-title":"Pharmacol Rev"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(98)00165-4","article-title":"Bradykinin receptors and their antagonists.","volume":"348","author":"D Regoli","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0162-3109(95)00011-H","article-title":"Kinin B1 receptors: a review.","volume":"30","author":"F Marceau","year":"1995","journal-title":"Immunopharmacology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1139\/cjpp-75-6-725","article-title":"The kinin B1 receptor: an inducible G protein coupled receptor.","volume":"75","author":"F Marceau","year":"1997","journal-title":"Can J Physiol Pharmacol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/pr.57.1.2","article-title":"International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences.","volume":"57","author":"LM Leeb-Lundberg","year":"2005","journal-title":"Pharmacol Rev"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0165-6147(99)01321-8","article-title":"B1 receptors as a new inflammatory target. Could this B the 1?","volume":"20","author":"A Ahluwalia","year":"1999","journal-title":"Trends Pharmacol Sci"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/sj.bjp.0702743","article-title":"Inducible expression of the kinin B1 receptor in the endotoxemic heart: mechanisms of des-Arg<sup>9<\/sup>bradykinin-induced coronary vasodilation.","volume":"128","author":"PG McLean","year":"1999","journal-title":"Br J Pharmacol"},{"key":"ref12","first-page":"79","article-title":"Activity of tissue and plasma kallikrein and level of their precursors in eye tissue structures and media of healthy rabbits.","volume":"37","author":"TP Kuznetsova","year":"1991","journal-title":"Vopr Med Khim"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/exer.1996.0087","article-title":"Expression and cellular localization of the kallikrein-kinin system in human ocular tissues.","volume":"63","author":"JX Ma","year":"1996","journal-title":"Exp Eye Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0162-3109(99)00057-0","article-title":"Localization of B2 bradykinin receptor mRNA in the rat retina and sclerocornea.","volume":"45","author":"H Takeda","year":"1999","journal-title":"Immunopharmacology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.lfs.2008.09.014","article-title":"Bradykinin stimulates glutamate uptake via both B1R and B2R activation in a human retinal pigment epithelial cells.","volume":"83","author":"SK Lim","year":"2008","journal-title":"Life Sci"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.bjp.0705210","article-title":"Early upregulation of kinin B1 receptors in retinal microvessels of the streptozotocin-diabetic rat.","volume":"140","author":"M Abdouh","year":"2003","journal-title":"Br J Pharmacol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/bjp.2008.48","article-title":"Retinal plasma extravasation in streptozotocin-diabetic rats mediated by kinin B(1) and B(2) receptors.","volume":"154","author":"M Abdouh","year":"2008","journal-title":"Br J Pharmacol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMra021678","article-title":"Diabetic retinopathy.","volume":"350","author":"RN Frank","year":"2004","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"43603","DOI":"10.1155\/2007\/43603","article-title":"Oxidative stress and diabetic retinopathy.","volume":"2007","author":"RA Kowluru","year":"2007","journal-title":"Exp Diabetes Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"95103","DOI":"10.1155\/2007\/95103","article-title":"Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy.","volume":"2007","author":"TS Kern","year":"2007","journal-title":"Exp Diabetes Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1096\/fj.03-1476fje","article-title":"A central role for inflammation in the pathogenesis of diabetic retinopathy.","volume":"18","author":"AM Joussen","year":"2004","journal-title":"FASEB J"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0002-9440(10)63952-1","article-title":"Leukocyte-mediated endothelial cell injury and death in the diabetic retina.","volume":"158","author":"AM Joussen","year":"2001","journal-title":"Am J Pathol"},{"key":"ref23","first-page":"2190","article-title":"In vivo demonstration of increased leukocyte entrapment in retinal microcirculation of diabetic rats.","volume":"39","author":"K Miyamoto","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"10836","DOI":"10.1073\/pnas.96.19.10836","article-title":"Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition.","volume":"96","author":"K Miyamoto","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1124\/jpet.105.098368","article-title":"Antinociceptive pharmacology of N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-2-[2-[[(4-methoxy-2,6-d imethylphenyl) sulfonyl]methylamino]ethoxy]-N-methylacetamide, fumarate (LF22-0542), a novel nonpeptidic bradykinin B1 receptor antagonist.","volume":"318","author":"F Porreca","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.npep.2007.09.005","article-title":"Involvement of kinin B1 receptor and oxidative stress in sensory abnormalities and arterial hypertension in an experimental rat model of insulin resistance.","volume":"41","author":"C Lungu","year":"2007","journal-title":"Neuropeptides"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.intimp.2007.09.009","article-title":"Role of kinin B1 and B2 receptors in a rat model of neuropathic pain.","volume":"8","author":"M Petcu","year":"2008","journal-title":"Int Immunopharmacol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) Method.","volume":"25","author":"KJ Livak","year":"2001","journal-title":"Methods"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1161\/01.RES.82.12.1298","article-title":"Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis.","volume":"82","author":"FJ Miller","year":"1998","journal-title":"Circ Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0161-6420(98)96025-0","article-title":"The 14-year incidence of visual loss in a diabetic population.","volume":"105","author":"SE Moss","year":"1998","journal-title":"Ophthalmology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000098495","article-title":"Pathophysiology of diabetic macular edema.","volume":"39","author":"AM Joussen","year":"2007","journal-title":"Dev Ophthalmol"},{"key":"ref32","first-page":"2408","article-title":"VEGF-initiated blood-retinal barrier breakdown in early diabetes.","volume":"42","author":"T Qaum","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.regpep.2004.09.002","article-title":"Enhanced dermal and retinal vascular permeability in streptozotocin-induced type 1 diabetes in Wistar rats: blockade with a selective bradykinin B1 receptor antagonist.","volume":"124","author":"SR Lawson","year":"2005","journal-title":"Regul Pept"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejphar.2005.03.023","article-title":"Effects of a selective bradykinin B1 receptor antagonist on increased plasma extravasation in streptozotocin-induced diabetic rats: distinct vasculopathic profile of major key organs.","volume":"514","author":"SR Lawson","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1139\/y02-153","article-title":"Inhibitory effect of a novel bradykinin B1 receptor antagonist, R-954, on enhanced vascular permeability in type 1 diabetic mice.","volume":"80","author":"B Simard","year":"2002","journal-title":"Can J Physiol Pharmacol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.2337\/db10-1260","article-title":"Plasma kallikrein mediates retinal vascular dysfunction and induces retinal thickening in diabetic rats.","volume":"60","author":"A Clermont","year":"2011","journal-title":"Diabetes"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1167\/iovs.07-0112","article-title":"Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.","volume":"48","author":"EC Leal","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0002-9440(10)65044-4","article-title":"Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1).","volume":"156","author":"K Miyamoto","year":"2000","journal-title":"Am J Pathol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1167\/iovs.05-0531","article-title":"Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage.","volume":"47","author":"AC Amrite","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S0002-9440(10)63728-5","article-title":"Simvastatin inhibits leukocyte accumulation and vascular permeability in the retinas of rats with streptozotocin-induced diabetes.","volume":"164","author":"S Miyahara","year":"2004","journal-title":"Am J Pathol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.exer.2009.07.010","article-title":"Vascular adhesion protein-1 regulates leukocyte transmigration rate in the retina during diabetes.","volume":"89","author":"K Noda","year":"2009","journal-title":"Exp Eye Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1515\/BC.2001.014","article-title":"Altered neutrophil homeostasis in kinin B1 receptor-deficient mice.","volume":"382","author":"RC Araujo","year":"2001","journal-title":"Biol Chem"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"8140","DOI":"10.1073\/pnas.120035997","article-title":"Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors.","volume":"97","author":"JB Pesquero","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1084\/jem.192.3.367","article-title":"Association between kinin B(1) receptor expression and leukocyte trafficking across mouse mesenteric postcapillary venules.","volume":"192","author":"PG McLean","year":"2000","journal-title":"J Exp Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.bjp.0701590","article-title":"Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy.","volume":"123","author":"RM Vianna","year":"1998","journal-title":"Br J Pharmacol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.bjp.0704999","article-title":"Up-regulation of kinin B1 receptor in the lung of streptozotocin-diabetic rat: autoradiographic and functional evidence.","volume":"138","author":"RM Vianna","year":"2003","journal-title":"Br J Pharmacol"},{"key":"ref47","first-page":"642","article-title":"Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid.","volume":"147","author":"DS McLeod","year":"1995","journal-title":"Am J Pathol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.exer.2011.03.007","article-title":"Modulation of retinal blood flow by kinin B<sub>1<\/sub> receptor in Streptozotocin-diabetic rats.","volume":"92","author":"M Pouliot","year":"2011","journal-title":"Exp Eye Res"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1167\/iovs.04-0633","article-title":"Role of interleukin-1beta in the development of retinopathy in rats: effect of antioxidants.","volume":"45","author":"RA Kowluru","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0014-2999(02)02793-0","article-title":"Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model.","volume":"458","author":"SP Ayalasomayajula","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"R735","DOI":"10.1152\/ajpregu.00080.2003","article-title":"Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats.","volume":"287","author":"Y Du","year":"2004","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0002-9394(01)01127-8","article-title":"Expression of the inducible isoform of nitric oxide synthase in the retinas of human subjects with diabetes mellitus.","volume":"132","author":"AM Abu El-Asrar","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.npep.2009.12.004","article-title":"Differential regulation of inducible and endothelial nitric oxide synthase by kinin B1 and B2 receptors.","volume":"44","author":"F Kuhr","year":"2010","journal-title":"Neuropeptides"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0002-9440(10)63311-1","article-title":"Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy.","volume":"165","author":"V Poulaki","year":"2004","journal-title":"Am J Pathol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.2337\/diabetes.50.8.1938","article-title":"Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy.","volume":"50","author":"RA Kowluru","year":"2001","journal-title":"Diabetes"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.freeradbiomed.2003.08.018","article-title":"Hyperglycemia increases mitochondrial superoxide in retina and retinal cells.","volume":"35","author":"Y Du","year":"2003","journal-title":"Free Radic Biol Med"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1167\/iovs.05-1276","article-title":"Role of mitochondrial superoxide dismutase in the development of diabetic retinopathy.","volume":"47","author":"RA Kowluru","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.exer.2006.03.024","article-title":"Expression modification of uncoupling proteins and MnSOD in retinal endothelial cells and pericytes induced by high glucose: the role of reactive oxygen species in diabetic retinopathy.","volume":"83","author":"Y Cui","year":"2006","journal-title":"Exp Eye Res"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1167\/iovs.06-1280","article-title":"Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase.","volume":"48","author":"M Kanwar","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00125-009-1655-6","article-title":"Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes.","volume":"53","author":"M Sasaki","year":"2010","journal-title":"Diabetologia"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.2337\/db08-0329","article-title":"Gene deletion of the kinin receptor B1 attenuates cardiac inflammation and fibrosis during the development of experimental diabetic cardiomyopathy.","volume":"58","author":"D Westermann","year":"2009","journal-title":"Diabetes"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"e12622","DOI":"10.1371\/journal.pone.0012622","article-title":"Kinin B1 receptor enhances the oxidative stress in a rat model of insulin resistance: outcome in hypertension, allodynia and metabolic complications.","volume":"5","author":"JP Dias","year":"2010","journal-title":"PLoS One"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ejphar.2004.07.045","article-title":"Putative roles of kinin receptors in the therapeutic effects of angiotensin 1-converting enzyme inhibitors in diabetes mellitus.","volume":"500","author":"R Couture","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1074\/jbc.273.5.2784","article-title":"Transcription factor nuclear factor kappaB regulates the inducible expression of the human B1 receptor gene in inflammation.","volume":"273","author":"A Ni","year":"1998","journal-title":"J Biol Chem"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0033864","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T07:31:34Z","timestamp":1742801494000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0033864"}},"subtitle":[],"editor":[{"given":"Alfred","family":"Lewin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,3,28]]},"references-count":64,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,3,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0033864","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,28]]}}}